Transcatheter aortic valve replacement-related aortic dissection: A clinical case series.
TAVI
aortic dissection
aortic injury
vascular complication
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
revised:
18
12
2022
received:
12
08
2022
accepted:
15
01
2023
pubmed:
27
1
2023
medline:
3
3
2023
entrez:
26
1
2023
Statut:
ppublish
Résumé
We review our experience with 13 periprocedural aortic dissection (AD) cases caused by transcatheter aortic valve replacement (TAVR). AD is a potentially lethal complication of TAVR; however, only sporadic case reports have been published to date. Among 1335 consecutive patients who underwent TAVR in 2013-2021, we retrospectively extracted 13 patients (1.0%) with TAVR-related AD (Stanford type A in 6 [46%], type B in 7 [54%]). AD was defined as a new-onset dissected layer of the aortic wall and diagnosed by aortography, computed tomography, or transesophageal echocardiography. Five of the six type A AD cases (83%) were detected during TAVR versus only one of the seven type B AD cases (14%). Four of the seven type B AD cases (57%) were asymptomatic and incidentally detected on computed tomography. The presumed causes of AD were injury by the delivery sheath (39%), delivery catheter (23%), valve implantation (15%), stent edge (15%), and pre-dilation balloon (8%). Complicated AD occurred in only one patient (8%). Considering the patient's age and prohibitive surgical risk, all patients were treated conservatively and free of any aortic-related deaths or interventions during a follow-up of 1087 days. TAVR-related AD is a rare but life-threatening condition that may be underdiagnosed. Its optimal therapy remains unclear, and conservative management might be an option for selected patients. Further studies are needed to elucidate the incidence, risk factors, effective screening, optimal therapy, and outcomes of TAVR-related AD.
Sections du résumé
OBJECTIVES
We review our experience with 13 periprocedural aortic dissection (AD) cases caused by transcatheter aortic valve replacement (TAVR).
BACKGROUND
AD is a potentially lethal complication of TAVR; however, only sporadic case reports have been published to date.
METHODS
Among 1335 consecutive patients who underwent TAVR in 2013-2021, we retrospectively extracted 13 patients (1.0%) with TAVR-related AD (Stanford type A in 6 [46%], type B in 7 [54%]). AD was defined as a new-onset dissected layer of the aortic wall and diagnosed by aortography, computed tomography, or transesophageal echocardiography.
RESULTS
Five of the six type A AD cases (83%) were detected during TAVR versus only one of the seven type B AD cases (14%). Four of the seven type B AD cases (57%) were asymptomatic and incidentally detected on computed tomography. The presumed causes of AD were injury by the delivery sheath (39%), delivery catheter (23%), valve implantation (15%), stent edge (15%), and pre-dilation balloon (8%). Complicated AD occurred in only one patient (8%). Considering the patient's age and prohibitive surgical risk, all patients were treated conservatively and free of any aortic-related deaths or interventions during a follow-up of 1087 days.
CONCLUSIONS
TAVR-related AD is a rare but life-threatening condition that may be underdiagnosed. Its optimal therapy remains unclear, and conservative management might be an option for selected patients. Further studies are needed to elucidate the incidence, risk factors, effective screening, optimal therapy, and outcomes of TAVR-related AD.
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
668-675Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006-3008.
Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT registry of transcatheter aortic valve replacement. JACC: Cardiovasc Interv. 2020;76:2492-2516.
Nguyen V, Willner N, Eltchaninoff H, et al. Trends in aortic valve replacement for aortic stenosis: a French nationwide study. Eur Heart J. 2022;43:666-679.
Hashemi H, Khera S, Anastasius M, et al. Acute type A aortic dissection after TAVR in an octogenarian with ascending aorta aneurysm. JACC: Cardiovasc Interv. 2022;15:220-222.
Yashima F, Hayashida K, Fukuda K. Delivery balloon-induced ascending aortic dissection: an unusual complication during transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2016;87:1338-1341.
Nagasawa A, Shirai S, Hanyu M, Arai Y, Kamioka N, Hayashi M. Descending aortic dissection injured by tip of the sheath during transcatheter aortic valve implantation. Cardiovasc Interv Ther. 2016;31:122-127.
Higuchi R, Tobaru T, Hagiya K, et al. Outcomes of patients requiring extracorporeal membrane oxygenation in transcatheter aortic valve implantation: a clinical case series. Heart Vessels. 2018;33:1343-1349.
Erbel R, Aboyans V, Boileau C, et al. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2873-2926.
Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials. JACC: Cardiovasc Interv. 2011;57:253-269.
Walther T, Hamm CW, Schuler G, et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements. JACC: Cardiovasc Interv. 2015;65:2173-2180.
Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62-69.
Yamaguchi R, Yamamoto M, Shimura T, Adachi Y, Sago M. Rescue percutaneous stenting for cerebral malperfusion with acute aortic dissection following TAVR. JACC: Case Rep. 2021;3:1700-1704.
Ong SH, Mueller R, Gerckens U. Iatrogenic dissection of the ascending aorta during TAVI sealed with the CoreValve revalving prosthesis. Catheter Cardiovasc Interv. 2011;77:910-914.
Pape LA, Awais M, Woznicki EM, et al. Presentation, diagnosis, and outcomes of acute aortic dissection. JACC: Cardiovasc Interv. 2015;66:350-358.
Kitai T, Kaji S, Yamamuro A, et al. Clinical outcomes of medical therapy and timely operation in initially diagnosed type a aortic intramural hematoma: a 20-year experience. Circulation. 2009;120:S292-S298.
Nienaber CA, Sakalihasan N, Clough RE, et al. Thoracic endovascular aortic repair (TEVAR) in proximal (type A) aortic dissection: ready for a broader application? J Thorac Cardiovasc Surg. 2017;153:S3-S11.
D'Onofrio A, Tessari C, Bianco R, Isabella G, Di Gregorio G, Gerosa G. Acute ascending aortic dissection during transaortic balloon-expandable aortic valve implantation. J Thorac Cardiovasc Surg. 2012;144:e97-e99.
Kawajiri H, Pochettino A. Chronic type A aortic dissection after transcatheter aortic valve replacement. Ann Thorac Surg. 2020;109:e431-e433.
Berfield KKS, Sweet MP, McCabe JM, et al. Endovascular repair for type A aortic dissection after transcatheter aortic valve replacement with a medtronic CoreValve. Ann Thorac Surg. 2015;100:1444-1446.
JCS/JSCS/JATS/JSVS 2020 Guideline on Diagnosis and Treatment of Aortic Aneurysm and Aortic Dissection. Accessed December 18, 2022 (in Japanese). https://www.j-circ.or.jp/guideline/guideline-series/
Moulakakis KG, Mylonas SN, Dalainas I, Kakisis J, Kotsis T, Liapis CD. Management of complicated and uncomplicated acute type B dissection. A systematic review and meta-analysis. Ann Cardiothorac Surg. 2014;3:234-246.
Nienaber CA, Kische S, Rousseau H, et al. Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial. Circ: Cardiovasc Interv. 2013;6:407-416.
Rujirachun P, Junyavoraluk A, Jakrapanichakul D, et al. Immediate aortic dissection after transcatheter aortic valve replacement: a case report and review of the literature. Clin Case Rep. 2021;9:e04412.
Baikoussis N, Argiriou M, Kratimenos T, Karameri V, Dedeilias P. Iatrogenic dissection of the descending aorta: conservative or endovascular treatment? Ann Card Anaesth. 2016;19:554-556.
Aminian A, Lalmand J, El Nakadi B. Perforation of the descending thoracic aorta during transcatheter aortic valve implantation (TAVI): an unexpected and dramatic procedural complication. Catheter Cardiovasc Interv. 2011;77:1076-1078.
Evangelista A, Isselbacher EM, Bossone E, et al. Insights from the international registry of acute aortic dissection: a 20-year experience of collaborative clinical research. Circulation. 2018;137:1846-1860.